Description    Increased levels of plasma cortisol leading to clinical signs are the result of either exogenous administration or endogenous production of glucocorticoids. Endogenous production usually results from a pituitary tumor producing excessive ACTH that stimulates the adrenal cortex. Unilateral or (rarely) bilateral adrenocortical neoplasia is the underlying cause in 15-20% of cases. Diabetes mellitus, secondary pyoderma, and calcinosis cutis might be seen and myotonia is a rare complication, often in older dogs. Neurologic signs of brain stem disease might be seen with a large pituitary tumor.
Species   Canine
Signs   Abdominal distention, Abnormal behavior, aggression, changing habits, Abnormal size testes/scrotum, Alopecia, Anestrus, Anisocoria, Anorexia, Ataxia, Back atrophy, Blindness, Bunny hopping, Circling, Cold skin, Coma, Corneal edema, opacity, Corneal ulcer, Decreased tearing, lacrimation, Disoriented, Dryness of skin or hair, Dullness, Dysmetria, Dyspnea, Enophthalmos, Exercise intolerance, Female infertility, Forelimb atrophy, Forelimb lameness, Generalized lameness or stiffness, Generalized weakness, Glucosuria, Head pressing, Head, face, ears, jaw weakness, droop, Head, face, jaw, tongue atrophy, Hepatosplenomegaly, Hindlimb atrophy, Hindlimb lameness, Hyperesthesia, Hypertonia of muscles, myotonia, Hyphema, Increased respiratory rate, Internal abdominal mass, Lack of libido or erection, Male infertility, Miosis, Moist skin, hair or feathers, Mydriasis, Oily skin, hair or feathers, greasy, Overweight, Petechiae, ecchymoses, purpura, Polydipsia, Polyphagia, Polyuria, Propulsion, Pruritus, Ptosis, Purulent discharge skin, Rough hair coat, Seizures or syncope, Skin crusts, Skin erythema, Skin hyperpigmentation, Skin or muscle dimple, Skin pain, Skin papules, Skin plaque, Skin pustules, Skin scales, Skin ulcer, Strabismus, Swelling mass, vulva, clitoris, Swelling skin or subcutaneous, Thin skin, Underweight, poor condition, thin, emaciated, unthriftiness, ill thrift, Weight loss
References   Lottati M. Outcomes of the addition of pasireotide to traditional adrenal-directed treatment for dogs with pituitary-dependent hyperadrenocorticism secondary to macroadenoma: 9 cases (20132015). JAVMA 2018;252:1403 [Web Reference]
Miller MA. Histopathologic Findings in Canine Pituitary Glands. Vet Pathol 2018;Apr [Web Reference]
Seckerdieck F. Recurrent pyoderma and its underlying primary diseases: a retrospective evaluation of 157 dogs. Vet Rec 2018;182:434 [Web Reference]
Beatrice L. Concurrent endocrine neoplasias in dogs and cats: a retrospective study (20042014). Vet Rec 2018;182:323 [Web Reference]
Bennaim M. Evaluation of individual low-dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs. J Vet Intern Med 2018;Mar [Web Reference]
Gershwin LJ. Current and Newly Emerging Autoimmune Diseases. Vet Clin North Am Small Anim Pract 2018;48:323 [Web Reference]
Reusch CE. Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment. J Vet Intern Med 2017;31:1643 [Web Reference]
Miceli DD. Concurrent hyperadrenocorticism and diabetes mellitus in dogs. Res Vet Sci 2017;115:425 [Web Reference]
Belanger JM. Correlation of neuter status and expression of heritable disorders. Canine Genet Epidemiol 2017;4:6 [Web Reference]
Kim K-h. Clinical Relationship between Cholestatic Disease and Pituitary-Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series. J Vet Intern Med 2017;31:335 [Web Reference]
Nagata N. Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated. J Vet Intern Med 2017;31:22 [Web Reference]
Copyright © 2018 Cornell University College of Veterinary Medicine